Dr. David Sutcliffe shows a video of the HeartWare ventricular assist device. Commonly used in adults, Children's Health is leading pioneering efforts to that are making VADs available for use in smaller, younger patients. Sutcliffe is holding the device in his hand. Photo: Lance Murray
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Self-driving 18-wheeler traffic on I-45 between Dallas and Houston just got a little busier.
Sweden-based Volvo Autonomous Solutions has announcement a partnership with Denmark-based logistics company DSV on autonomous freight operations in Texas....
Beyond Samsung Electronics Co., other organizations with notable patents granted this week include:
Swiss global pharmaceutical giant Novartis recently broke ground on its new radioligand therapy (RLT) manufacturing site in Denton, part of its broader $23 billion investment in U.S. manufacturing and research.
When completed in 2028, the company’s first Texas‑based manufacturing facility will bring RLT medications closer to patients across the southern United States, becoming the fifth RLT site nationwide, Novartis said....
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
Self-driving 18-wheeler traffic on I-45 between Dallas and Houston just got a little busier.
Sweden-based Volvo Autonomous Solutions has announcement a partnership with Denmark-based logistics company DSV on autonomous freight operations in Texas....
Beyond Samsung Electronics Co., other organizations with notable patents granted this week include:
Swiss global pharmaceutical giant Novartis recently broke ground on its new radioligand therapy (RLT) manufacturing site in Denton, part of its broader $23 billion investment in U.S. manufacturing and research.
When completed in 2028, the company’s first Texas‑based manufacturing facility will bring RLT medications closer to patients across the southern United States, becoming the fifth RLT site nationwide, Novartis said....
A collaboration of the Dallas Regional Chamber and Dallas Next, Dallas Innovates is an online news platform covering what's new + next in Dallas-Fort Worth innovation.
[email protected]© Copyright 2026 | All rights reserved.
